Bull World Health Organ. 1981;59(6):857-63.
This Memorandum outlines recommended safety tests for application to biological agents under consideration for widespread use for pest control. The basic principles utilized in developing these recommendations were that: (i) the hazards presented by microbial pesticides are inherently different from those associated with chemical pesticides and the tests used to determine hazard potential to man should reflect this; (ii) a high proportion of negative results is likely; (iii) tiered testing systems should be used; negative data obtained at any level would obviate the need for further testing; (iv) the primary tier testing protocols should be designed to expose test animals to the microbial agents under conditions that provide maximum opportunity for the expression of any adverse effects.Outlines of tests proposed for use with four groups of biological agents (bacteria, fungi, protozoa, and viruses) are given. The safety tests required at each level of development of a microbial agent are described.The present status of safety testing of the agents already under development for possible use in vector control is considered. It is concluded that, for Bacillus thuringiensis H-14 and B. sphaericus, a level of safety testing has been reached that permits their use in large-scale field trials.Suggestions for applied research are made, covering safety aspects of cottage-industry production of microbial agents, studies on allergic responses, serological surveys on laboratory workers, and the investigation of environmental persistence of newly developed agents.
本备忘录概述了针对正在考虑广泛用于害虫防治的生物制剂的推荐安全性测试。制定这些建议所采用的基本原则是:(i) 微生物农药所呈现的危害与化学农药相关的危害本质上不同,用于确定对人类潜在危害的测试应反映这一点;(ii) 很可能会有很高比例的阴性结果;(iii) 应使用分层测试系统;在任何层面获得的阴性数据都将无需进一步测试;(iv) 初级分层测试方案的设计应使实验动物在能最大程度表达任何不良反应的条件下接触微生物制剂。给出了针对四类生物制剂(细菌、真菌、原生动物和病毒)提议使用的测试概述。描述了微生物制剂在每个研发阶段所需的安全性测试。考虑了已在研发中可能用于病媒控制的制剂的安全性测试现状。得出的结论是,对于苏云金芽孢杆菌H - 14和球形芽孢杆菌,已达到一定程度的安全性测试,允许它们用于大规模田间试验。提出了应用研究建议,涵盖微生物制剂家庭作坊式生产的安全方面、过敏反应研究、实验室工作人员的血清学调查以及新研发制剂的环境持久性调查。